DUBLIN — In his Tuesday newsletter, Biznews boss Alec Hogg outlined the story of how Roundup, the world's most widely used week-killer, ended up on the losing side of a series of high-profile cancer claims. This detailed piece by the WSJ gives the full story of what has been happening. It's an interesting read on many levels, not least of which is that it is bring closer scrutiny to the relationship between science and big business. Studies show that when companies fund research, researchers are much more likely to have findings that favour the companies, even as they insist that they have no bias. As always, he who pays the piper calls the tune. This underscores the importance government-funded scientific research, which can serve as an important balance to the corporate-funded variety. Science is expensive, especially these days. It's dangerous to let any one group dominate its funding. – Felicity Duncan

Roundup, the world's best-selling weedkiller, faces a legal reckoning

By Jacob Bunge and Ruth Bender

For years, scientists at Monsanto Co. worked closely with outside researchers on studies that concluded its Roundup weedkiller was safe.

___STEADY_PAYWALL___